Largest health care pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 health care pharmaceutical companies ranked by earnings, at NOK 261.6B, ahead of Eli Lilly (NOK 201.5B) and Merck & Co (NOK 178.2B). Figures as of 19 Nov 2026, 22:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonNOK 261.6B
- Median
- NOK 575.9M
- Combined market value
- NOK 48.43T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | NOK 261.6B | NOK 6.28T | NOK 2,607.39 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | NOK 201.5B | NOK 11.75T | NOK 13,187.46 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | NOK 178.2B | NOK 3.2T | NOK 1,296.28 | 3.61% down | 45% up | ||
| 4 | Novo NordiskNVO · Health Care | NOK 148.4B | NOK 1.67T | NOK 379.39 | 1.42% down | 17% down | ||
| 5 | NovartisNVS · Health Care | NOK 136.5B | NOK 2.79T | NOK 1,475.97 | 2.57% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | NOK 99.8B | NOK 2.66T | NOK 1,712.07 | 1.87% down | 1% up | ||
| 7 | SanofiSNY · Health Care | NOK 84.6B | NOK 1.08T | NOK 449.56 | 2.25% down | 4% down | ||
| 8 | PfizerPFE · Health Care | NOK 75.8B | NOK 1.53T | NOK 268.80 | 1.85% down | 15% up | ||
| 9 | GSKGSK · Health Care | NOK 74.1B | NOK 935.6B | NOK 466.74 | 1.56% down | 5% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | NOK 68.8B | NOK 1.16T | NOK 569.42 | 2.05% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | NOK 63.7B | NOK 1.76T | NOK 1,013.81 | 0.58% down | 16% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | NOK 44B | NOK 932.3B | NOK 9,012.16 | 2.35% down | 28% up | ||
| 13 | AbbVieABBV · Health Care | NOK 41.2B | NOK 4.89T | NOK 2,767.46 | 0.86% down | 25% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | NOK 38.6B | NOK 1.29T | NOK 5,081.84 | 2.94% down | 27% up | ||
| 15 | ZoetisZTS · Health Care | NOK 26.1B | NOK 320.4B | NOK 788.54 | 5.59% down | 26% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 13.8B | NOK 438.9B | NOK 376.17 | 8.74% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | NOK 13B | NOK 232.4B | NOK 5,457.03 | 3.16% down | 22% up | ||
| 18 | GenmabGMAB · Health Care | NOK 9.4B | NOK 309B | NOK 501.20 | 0.75% up | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | NOK 7.5B | NOK 380.1B | NOK 660.97 | 1.38% down | 79% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | NOK 6.7B | NOK 47.6B | NOK 569.27 | 3.16% down | 21% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 4.5B | NOK 120.7B | NOK 144.75 | 1.00% down | 8% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | NOK 4.4B | NOK 95.7B | NOK 633.25 | 1.88% down | 117% up | ||
| 23 | GrifolsGRFS · Health Care | NOK 4.4B | NOK 54.5B | NOK 80.04 | 3.19% down | 0% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | NOK 3.4B | NOK 116.1B | NOK 599.48 | 0.02% down | 17% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | NOK 3.1B | NOK 193.2B | NOK 1,442.78 | 1.06% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | NOK 2.8B | NOK 445.6B | NOK 3,901.23 | 0.97% down | 16% up | ||
| 27 | AlkermesALKS · Health Care | NOK 2.4B | NOK 75.7B | NOK 450.73 | 1.43% down | 66% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.2B | NOK 56B | NOK 2,800.65 | 3.94% down | 50% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | NOK 972.6M | NOK 69.4B | NOK 634.23 | 4.15% down | 10% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | NOK 703.3M | NOK 72.7B | NOK 208.77 | 2.24% down | 90% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 575.9M | NOK 71.7B | NOK 912.94 | 1.59% down | 129% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -NOK 15.9M | NOK 60.2B | NOK 426.04 | 1.25% up | 13% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -NOK 228M | NOK 60.9B | NOK 932.21 | 3.27% up | 34% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -NOK 249.3M | NOK 45.3B | NOK 471.43 | 3.86% down | 45% up | ||
| 35 | VeradermicsMANE · Health Care | -NOK 683.2M | NOK 51.2B | NOK 1,214.09 | 0.38% down | 231% up | ||
| 36 | Belite BioBLTE · Health Care | -NOK 757.5M | NOK 59.9B | NOK 1,474.01 | 3.33% down | 43% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -NOK 1B | NOK 64.6B | NOK 952.32 | 1.91% up | 255% up | ||
| 38 | ErascaERAS · Health Care | -NOK 1.2B | NOK 48.7B | NOK 138.79 | 3.34% up | 395% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -NOK 1.3B | NOK 79B | NOK 1,210.48 | 2.47% down | 51% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -NOK 1.5B | NOK 90.5B | NOK 952.91 | 3.77% down | 332% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -NOK 1.6B | NOK 46.6B | NOK 827.97 | 1.01% up | 108% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -NOK 1.6B | NOK 44B | NOK 401.84 | 0.48% down | 86% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -NOK 1.8B | NOK 69.7B | NOK 1,324.29 | 1.25% up | 6% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -NOK 1.8B | NOK 39.4B | NOK 287.74 | 1.24% up | 168% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -NOK 1.9B | NOK 79B | NOK 1,140.01 | 1.88% down | 18% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -NOK 2.3B | NOK 128.3B | NOK 256.60 | 1.54% down | 26% up | ||
| 47 | Ascendis PharmaASND · Health Care | -NOK 2.5B | NOK 163.9B | NOK 2,498.27 | 5.32% down | 29% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -NOK 2.8B | NOK 90B | NOK 3,872.34 | 0.34% down | 27% down | ||
| 49 | Legend BiotechLEGN · Health Care | -NOK 2.9B | NOK 30.5B | NOK 157.14 | 0.92% down | 41% down | ||
| 50 | Roivant SciencesROIV · Health Care | -NOK 2.9B | NOK 275.5B | NOK 380.26 | 0.59% up | 91% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -NOK 3B | NOK 84.8B | NOK 3,034.51 | 1.87% up | 86% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -NOK 3.2B | NOK 47.1B | NOK 270.75 | 0.25% down | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -NOK 3.5B | NOK 148.1B | NOK 2,307.84 | 4.57% down | 41% up | ||
| 54 | ABIVAXABVX · Health Care | -NOK 3.6B | NOK 68.9B | NOK 787.18 | 3.79% down | 32% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -NOK 3.7B | NOK 44.2B | NOK 265.68 | 0.62% down | 63% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -NOK 7.2B | NOK 148.6B | NOK 763.07 | 0.22% up | 21% up | ||
| 57 | CytokineticsCYTK · Health Care | -NOK 7.7B | NOK 70B | NOK 502.27 | 0.27% up | 19% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -NOK 9.3B | NOK 667.6B | NOK 208.97 | 0.66% up | 51% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -NOK 10.5B | NOK 82.5B | NOK 103.17 | 0.67% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -NOK 12.5B | NOK 309.3B | NOK 1,409.99 | 20.58% up | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -NOK 34.3B | NOK 222.5B | NOK 194.04 | 1.97% down | 99% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7604 NOK).
Questions and answers
Which health care pharmaceutical companies rank first by earnings?
Johnson & Johnson (NOK 261.6B), Eli Lilly (NOK 201.5B) and Merck & Co (NOK 178.2B) are the top three of the 61 health care pharmaceutical companies ranked by earnings as of 19 Nov 2026, 22:51 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by earnings have a combined market value of NOK 48.43T as of 19 Nov 2026, 22:51 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.